Inhibrx, Inc. Quarterly Debt-to-equity in % from Q2 2021 to Q1 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Inhibrx, Inc. quarterly Debt-to-equity history and growth rate from Q2 2021 to Q1 2024.
  • Inhibrx, Inc. Debt-to-equity for the quarter ending March 31, 2024 was 640 %, a 75.6% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 640 -1.98K -75.6% Mar 31, 2024
Q4 2023 602 -1.08K -64.2% Dec 31, 2023
Q3 2023 535 -1.05K -66.2% Sep 30, 2023
Q2 2023 6.82K +6.31K +1223% Jun 30, 2023
Q1 2023 2.62K +2.33K +826% Mar 31, 2023
Q4 2022 1.68K +1.49K +766% Dec 31, 2022
Q3 2022 1.58K +1.43K +899% Sep 30, 2022
Q2 2022 515 +412 +398% Jun 30, 2022
Q1 2022 283 Mar 31, 2022
Q4 2021 194 Dec 31, 2021
Q3 2021 159 Sep 30, 2021
Q2 2021 103 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.